Overview

Selegiline for Smoking Cessation - 1

Status:
Completed

Trial end date:
2009-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is designed to examine the effects of Selegiline Transdermal System and behavioral intervention in smoking cessation as compared to behavioral intervention alone.

Phase:

Phase 2

Details

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Collaborator:

VA Office of Research and Development

Treatments:

Selegiline